GRHL2 and cancer: Associations between GRHL2 expression and clinical outcome in different cancer types reported so far mostly, but not exclusively, are based on differences in GRHL2 expression determined using publicly available omics datasets and, not surprisingly, in many cases even yielded contradictory results (reviewed in (1)).